Yan-Hua Qi1, Fei Teng2,3, Qi Zhou1, Yu-Xin Liu4, Jin-Fang Wu2, Shan-Shan Yu1, Xin Zhang2, Miao-Yan Ma1, Ni Zhou2, Li-Juan Chen2. 1. Department of Ultrasound, the Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. 2. Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. 3. Department of Obstetrics and Gynecology, First Affiliated Hospital, Lanzhou University, Lan Zhou, Gansu Province, China. 4. Human Resources, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Abstract
INTRODUCTION: Cell-free fetal DNA in maternal plasma is associated with complications of pregnancy, including preeclampsia. Determination of levels is affected by fetal gender and genetic polymorphisms. Unmethylated maspin (u-maspin) is present in the placenta, and is placental-specific. The purpose of this study was to determine whether u-maspin DNA in maternal blood could serve as a marker of preeclampsia by measuring levels in different trimesters of normal pregnancies and in those complicated by preeclampsia. MATERIAL AND METHODS: This case-control study was set in a tertiary care hospital. The population consisted of 45 women with normal pregnancies (15 in the 1st trimester, 15 in the 2nd trimester, 15 in the 3rd trimester), 20 women with mild preeclampsia, 25 women with severe preeclampsia, and six women with gestational trophoblastic disease. Peripheral blood was collected and methylation-specific PCR and fluorescence quantitative PCR were performed to measure the content of u-maspin DNA in maternal blood. RESULTS: U-maspin DNA was 5.5-fold higher in women with severe preeclampsia than in those with a normal 3rd trimester pregnancy (p < 0.05). During normal pregnancy, u-maspin DNA in maternal plasma tended to increase with advancing gestational age (p = 0.06). U-maspin DNA was not detected in healthy non-pregnant women or those with gestational trophoblastic disease. CONCLUSION: U-maspin DNA in maternal blood is associated with severe preeclampsia.
INTRODUCTION: Cell-free fetal DNA in maternal plasma is associated with complications of pregnancy, including preeclampsia. Determination of levels is affected by fetal gender and genetic polymorphisms. Unmethylated maspin (u-maspin) is present in the placenta, and is placental-specific. The purpose of this study was to determine whether u-maspin DNA in maternal blood could serve as a marker of preeclampsia by measuring levels in different trimesters of normal pregnancies and in those complicated by preeclampsia. MATERIAL AND METHODS: This case-control study was set in a tertiary care hospital. The population consisted of 45 women with normal pregnancies (15 in the 1st trimester, 15 in the 2nd trimester, 15 in the 3rd trimester), 20 women with mild preeclampsia, 25 women with severe preeclampsia, and six women with gestational trophoblastic disease. Peripheral blood was collected and methylation-specific PCR and fluorescence quantitative PCR were performed to measure the content of u-maspin DNA in maternal blood. RESULTS: U-maspin DNA was 5.5-fold higher in women with severe preeclampsia than in those with a normal 3rd trimester pregnancy (p < 0.05). During normal pregnancy, u-maspin DNA in maternal plasma tended to increase with advancing gestational age (p = 0.06). U-maspin DNA was not detected in healthy non-pregnant women or those with gestational trophoblastic disease. CONCLUSION: U-maspin DNA in maternal blood is associated with severe preeclampsia.
Authors: Sijana H Dzinic; Maria M Bernardo; Daniel S M Oliveira; Marian Wahba; Wael Sakr; Shijie Sheng Journal: Bosn J Basic Med Sci Date: 2015-10-25 Impact factor: 3.363
Authors: Victor Yuan; E Magda Price; Giulia Del Gobbo; Sara Mostafavi; Brian Cox; Alexandra M Binder; Karin B Michels; Carmen Marsit; Wendy P Robinson Journal: Epigenetics Chromatin Date: 2019-08-09 Impact factor: 4.954
Authors: A Cirkovic; V Garovic; J Milin Lazovic; O Milicevic; M Savic; N Rajovic; N Aleksic; T Weissgerber; A Stefanovic; D Stanisavljevic; N Milic Journal: Biol Sex Differ Date: 2020-07-06 Impact factor: 5.027